{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:08:48Z","timestamp":1759972128331,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.braindev.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T17:57:07Z","timestamp":1581616627000},"page":"322-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A questionnaire survey on the efficacy of various treatments for dyskinetic cerebral palsy due to preterm bilirubin encephalopathy"],"prefix":"10.1016","volume":"42","author":[{"given":"Yukihiro","family":"Kitai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satori","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Hirotsune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2020.01.006_b0005","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1542\/peds.2008-2791","article-title":"Kernicterus in preterm infants","volume":"123","author":"Okumura","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2020.01.006_b0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ped.12651","article-title":"Current incidence of clinical kernicterus in preterm infants in Japan","volume":"57","author":"Morioka","year":"2015","journal-title":"Pediatr Int"},{"key":"10.1016\/j.braindev.2020.01.006_b0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/ped.13635","article-title":"Hyperbilirubinemia in preterm infants in Japan: New treatment criteria","volume":"60","author":"Morioka","year":"2018","journal-title":"Pediatr Int"},{"key":"10.1016\/j.braindev.2020.01.006_b0020","first-page":"1","article-title":"Diagnosis of bilirubin encephalopathy in preterm infants with dyskinetic cerebral palsy","author":"Kitai","year":"2019","journal-title":"Neonatology"},{"key":"10.1016\/j.braindev.2020.01.006_b0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1474-4422(17)30252-1","article-title":"Clinical presentation and management of dyskinetic cerebral palsy","volume":"16","author":"Monbaliu","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0030","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1469-8749.1962.tb03177.x","article-title":"Clinical experiences with chlordiazepoxide (librium) in infantile cerebral palsy","volume":"4","author":"Keats","year":"1962","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1469-8749.1962.tb03175.x","article-title":"Primidone and chlordiazepoxide in cerebral palsy","volume":"4","author":"Thorn","year":"1962","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpn.2015.09.007","article-title":"Gabapentin can significantly improve dystonia severity and quality of life in children","volume":"20","author":"Liow","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0045","unstructured":"AACPDM Care Pathway [Internet]. c 2016 September [Updated 2018 June 4] Available from: https:\/\/www.aacpdm.org\/publications\/care-pathways\/dystonia."},{"key":"10.1016\/j.braindev.2020.01.006_b0050","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/dmcn.13532","article-title":"Efficacy of oral pharmacological treatments in dyskinetic cerebral palsy: a systematic review","volume":"59","author":"Masson","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/dmcn.13652","article-title":"Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review","volume":"60","author":"Fehlings","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0060","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/toxins7051629","article-title":"Best clinical practice in botulinum toxin treatment for children with cerebral palsy","volume":"7","author":"Strobl","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.braindev.2020.01.006_b0065","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1017\/S0012162201001190","article-title":"Intrathecal baclofen for generalized dystonia","volume":"43","author":"Albright","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/BPO.0b013e3181653b2a","article-title":"Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales","volume":"28","author":"Motta","year":"2008","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.braindev.2020.01.006_b0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ejpn.2016.02.013","article-title":"The effect of intrathecal baclofen treatment on activities of daily life in children and young adults with cerebral palsy and progressive neurological disorders","volume":"20","author":"Bonouvrie","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0080","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/dmcn.13625","article-title":"Intrathecal baclofen in dyskinetic cerebral palsy: effects on function and activity","volume":"60","author":"Eek","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0085","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejpn.2016.02.006","article-title":"Progression to musculoskeletal deformity in childhood dystonia","volume":"20","author":"Lumsden","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(09)70151-6","article-title":"Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study","volume":"8","author":"Vidailhet","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mds.25339","article-title":"Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis","volume":"28","author":"Koy","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.braindev.2020.01.006_b0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpn.2016.05.015","article-title":"Deep brain stimulation in cerebral palsy: challenges and opportunities","volume":"21","author":"Koy","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejpn.2017.12.002","article-title":"Deep brain stimulation for dystonia due to cerebral palsy: a review","volume":"22","author":"Elia","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0110","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0883073813488674","article-title":"Pallidal stimulation in children: comparison between cerebral palsy and DYT1 dystonia","volume":"28","author":"Marks","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2020.01.006_b0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejpn.2016.06.002","article-title":"PEDiDBS: The pediatric international deep brain stimulation registry project","volume":"21","author":"Marks","year":"2017","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420300322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760420300322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:48:43Z","timestamp":1759952923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760420300322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0387760420300322"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2020.01.006","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A questionnaire survey on the efficacy of various treatments for dyskinetic cerebral palsy due to preterm bilirubin encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}